In this cohort of women with GDM followed during pregnancy up 1 year postpartum, CRP in the perinatal period predicted a more adverse metabolic profile including insulin resistance, decreased adjusted insulin secretion and metabolic syndrome that was largely independent of GA, age, previous history of GDM, family history of diabetes and weight and in part of body fat. The gene discussed is CRP; the disease is diabetes mellitus.